The global Urinary Tract Infection (UTI) Testing Market was valued at USD 5.47 billion in 2025. The market is anticipated to reach USD 9.98 billion by 2035, expanding at a CAGR of 6.2% during the forecast period. In 2025, the Urinalysis segment accounted for a market share of 63.4%, whereas the Hospital Laboratories segment represented a share of 54.7%.
A key development took place in June 2024 when Sysmex Astrego won the prestigious £8 million Longitude Prize on Antimicrobial Resistance for its PA-100 AST System. This system can detect UTI pathogens and antibiotic susceptibility within 45 minutes, representing a major advancement over conventional methods that take two to three days. This innovation reflects the industry's shift towards rapid, point-of-care diagnostics critical for combating antimicrobial resistance and improving treatment accuracy.
The demand for UTI testing products is being driven by an increasing prevalence of urinary tract infections, particularly in women and elderly populations worldwide. Rising awareness about early detection and the advantages of rapid diagnostic testing are encouraging healthcare providers to adopt cost-effective urinalysis methods. Hospital laboratories dominate the end-user segment owing to their advanced diagnostic infrastructure, high sample volumes, and need for reliable results.
Technological advancements are further shaping the market. Companies are developing home-based testing kits integrated with telehealth platforms, such as Winx Health’s “Test + Treat” UTI kit, enhancing patient convenience. These solutions allow patients to conduct tests at home and receive instant medical consultations, promoting decentralization of diagnostic services.
Regionally, North America leads due to superior healthcare infrastructure and higher disease awareness, while Asia-Pacific and Latin America are set to witness faster growth supported by increasing healthcare spending and accessibility of diagnostics. Rising disposable income and government initiatives to control antimicrobial resistance are spurring market development in these regions.
Leading companies such as Qiagen (Roche), Danaher Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories, Sysmex Corporation, and Accelerate Diagnostics are continuously launching improved test solutions and expanding their geographic presence. These firms focus on enhancing test accuracy, reducing result turnaround times, and integrating digital health technologies.
Market Metrics
| Metric | Value |
|---|---|
| Industry Size (2025E) | USD 5.47 billion |
| Industry Value (2035F) | USD 9.98 billion |
| CAGR (2025 to 2035) | 6.2% |
In 2025, the Urinalysis segment is expected to dominate the UTI Testing Market with a market share of 63.4%, driven by its cost-effectiveness and rapid diagnostic capabilities. Hospital Laboratories are forecasted to lead the end user category, capturing a 54.7% market share owing to advanced diagnostic infrastructure and increased demand for reliable infection detection systems.
The Urinalysis segment will command the largest market share of 63.4% in 2025 within the UTI Testing Market. This growth is driven by urinalysis’ role as a first-line diagnostic tool due to its affordability, rapid turnaround, and high accessibility in hospitals, diagnostic labs, and outpatient settings. Recent advancements in automated urinalysis systems-such as the inclusion of flow cytometry and digital microscopy-enhance the accuracy of results, supporting early-stage UTI detection.
In addition, the rising geriatric population and the growing prevalence of recurrent UTIs are fueling demand for rapid diagnostic solutions. Portable point-of-care (POC) urinalysis devices are increasingly adopted in emergency departments and outpatient clinics for immediate clinical decision-making. The emergence of home-based urinalysis test kits, offering convenience and remote monitoring, is also widening market reach.
Leading diagnostics companies such as Siemens Healthineers, Sysmex Corporation, and Beckman Coulter are focusing on automation and multiplexing innovations to make urinalysis more comprehensive and efficient, ensuring this segment’s continued dominance over traditional culture methods.
Hospital Laboratories are projected to lead the end user segment with a market share of 54.7% in 2025, maintaining their pivotal role in UTI diagnostics. This dominance stems from hospitals’ ability to handle high patient volumes and their investment in modern diagnostic equipment essential for accurate and efficient UTI testing.
Hospitals are increasingly adopting automated urinalysis and culture platforms to improve diagnostic accuracy, minimize manual errors, and accelerate reporting times. Integration with Laboratory Information Systems (LIS) has streamlined sample processing and data management, enhancing overall workflow efficiency.
Furthermore, hospital laboratories conduct the majority of antibiotic susceptibility testing, crucial for tailoring treatments to drug-resistant UTI strains-an escalating concern due to the global rise in antimicrobial resistance. Hospitals also participate actively in antimicrobial stewardship programs, making laboratory-based diagnostics vital for infection control measures.
Prominent players like Becton Dickinson, BioMérieux, and Roche Diagnostics are advancing hospital-grade diagnostic systems with real-time data analysis capabilities. With continuous innovation and automation, hospital laboratories will remain central to driving the UTI testing market’s growth trajectory.
Diagnostic Accuracy and Cost Constraints Limit UTI Testing Adoption
Expensive diagnostic tests with cutting-edge technology, regulatory hurdles, and fear of inaccuracy in home-based testing kits are still significant hindrances. Inadequate awareness in developing markets could also delay the pace of adoption. Antibiotic resistance is a huge challenge resulting in misdiagnosis and suboptimal treatment in certain situations.
The availability of spurious and low-quality test kits in the low and middle income countries makes the scenario even more challenging and thus necessitating increased enforcement of quality control protocols. These challenges need to be addressed with increased investment in awareness campaigns, enhanced diagnostic standardization, and increased affordability of high-quality testing solutions.
PCR Technology Reshaping UTI Diagnostics
Urinary tract infections affect millions of cases worldwide, making timely and accurate diagnosis essential for effective treatment for patients. With technological advancements PCR based testing is revolutionizing UTI diagnostics, offering manufacturers significant growth opportunities.
PCR technology enhances accuracy by amplifying specific DNA sequences which is enabling precise pathogen identification and antibiotic resistance detection. This breakthrough allows manufacturers to develop advanced PCR-based diagnostic tools that address the rising demand for rapid and reliable UTI testing.
Multiplex PCR assays will further improve diagnostics by simultaneously detecting multiple pathogens streamlining testing process and reducing turnaround time for results. Manufacturers are investing in multiplex panels can provide comprehensive, time-efficient solutions for healthcare professionals.
Industry focus towards high-accuracy, rapid and comprehensive diagnostic tools will drive the market expansion and meet evolving healthcare needs, strengthening their competitive position in the urinary tract infection testing market.
Market Outlook
The urinary tract infection testing industry in United States is on growth phase, essentially propelled by the increasing UTI cases each year along with the strides made in diagnostic procedures. In addition to that, the demands for proper testing tools and developments of new testing modalities are also driving the demand for urinary tract infection testing market.
Rising elderly population who are more prone to urinary tract infections also adds value to the overall market. Shift towards the use of rapid point-of-care testing and home-based self-test kits are the new features of the market which are allowing for quantitative testing, early diagnosis, fast treatment and positive patient outcomes
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| United States | 3.3% |
Market Outlook
Urinary tract infection testing market in Germany has experienced significant growth, which is attributable to the very reliable healthcare system. A systematic and proactive approach towards infectious diseases diagnostics that makes this country one of the leading market in Europe contributing a significant market share.
The rise in preventive care and free UTI testing are often offered to patients which remain as a key reasons for the growing demand for UTI testing. The use of modern diagnostic tools remains as another factor driving growth across hospitals and diagnostic laboratory settings which is able to detect UTI much faster and with greater accuracy.
Market Growth Factors
Market Forecast
| Year | CAGR (2025 to 2035) |
|---|---|
| 2025 to 2035 | 2.9% |
Market Outlook
The market for urinary tract infection testing in India is experiencing rapid expansion. This growth is attributed to several key reasons such as increased prevalence of urinary tract infections in both rural and urban areas. The high incidence of diabetes and rising cases of antibiotic-resistant infections are two critical factors driving the need for efficient and accurate UTI testing.
Ongoing efforts include government healthcare campaigns and the establishment of new diagnostic laboratories, particularly benefiting remote locations where UTI testing has become more accessible.
Other contributing factors to market growth are well-furnished healthcare facilities and specialty clinics that provide clear diagnostic testing tools and options. The acceptance of home testing or self-testing has gained importance and is a significant reason for the market's expansion.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| India | 7.9% |
Market Outlook
The urinary tract infection testing market in Japan is witnessing significant growth owing to the growing of the aging population and development of technological advancement concerning the diagnostic sector. Primarily speaking, the elderly people do have a lot of UTIs and the situation is worsened by the fact that they stay in long-term care settings where the presence of this kind of disease has an impact.
The integration of molecular diagnostics together with the automation of diagnostic labs is the other side of the coin when it comes to the growth of the trend. The popularity of point-of-care (POC) and home-based UTI kits has improved the availability and speed of diagnostics in the market.
Market Growth Factors
Aging Population and Increasing UTI Prevalence: Japan older population is on the rise especially in assisted living and nursing facilities which have observed a consistent increase in UTI cases. Thus, the necessity for dependable disease diagnosis across clinical and home settings has become prominent
Advances in Diagnostic Automation: The focus on automated urinalysis systems and molecular diagnostics has led to the fast testing and accuracy of results.
Strong Emphasis on Preventive Healthcare: Government health screening programs also serve to directly address the issue of infectious diseases by early detection of urinary tract infections, thus inflating the number of diagnostic tests available, and the need for reliable test results.
Increased Demand for Point-of-Care (POC) Testing: The implementation of rapid UTI be at the outpatient clinics and the pharmacies, it has made the treatment decisions faster and less hospital participation, thus making the system better.
Growing Home-Based Testing Solutions: The self-testing kits that are now available for urinary tract infections provide more comfort to users and at the same time, they relieve the hospitals from the burden of carrying out the tests themselves and by doing so, they facilitate the patients with quicker access to the treatment decision.
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 3.8% |
Market Outlook
Urinary tract infection testing market in Brazil is growing due to advancement in healthcare infrastructure, increasing penetration of new diagnostic laboratories, increasing installation of Urine Analyzers and heightened awareness of infectious disease prevention.
The government is emphasizing on strengthening public health services, rising testing volume and increasing incidence of UTIs are key reasons for the demand for diagnostic testing
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| Brazil | 6.2% |
The urinary tract infection testing industry is highly competitive, and it is influenced by major international players and regional players. Increased prevalence of UTIs, evolution of diagnostic technology, and increasing focus on early diagnosis have caused the development of UTI testing technologies.
There is investment in rapid, efficient, and convenient testing solutions to remain competitive. The market is dominated by established diagnostic companies and new brands, each of which plays a part in the dynamic picture of UTI diagnostics.
F. Hoffmann-La Roche AG (18-22%)
Roche is a diagnostics world leader that has a comprehensive product portfolio in urinalysis designed to streamline the detection of UTI and enable clinical decision-making. Innovation and automation are highly valued to enhance diagnostic quality and efficiency.
Siemens Healthineers AG (12-16%)
Siemens Healthineers offers state-of-the-art urinalysis instruments that fit nicely into laboratory practices. Their technologies improve diagnostic efficiency, providing high-throughput analysis for clinical labs.
Danaher (10-14%)
This company, with a wide portfolio of laboratory products, is a category leader and facilitates UTI testing through consistent culture media and quick identification aids. The company serves both clinical and research requirements, providing complete diagnostic capabilities.
Thermo Fisher Scientific Inc (8-12%)
Focusing on microbiology, This organization provides automated systems for urine culture and antimicrobial susceptibility testing to assist with accurate UTI diagnosis and optimal treatment planning.
Abbott (6-10%)
Abbott is dedicated to point-of-care diagnostics, offering easy-to-use urinalysis products that enable timely UTI identification in a variety of healthcare settings.
Beyond the leading companies, several other manufacturers contribute significantly to the market, enhancing product diversity and technological advancements. These include:
These companies focus on expanding the reach of professional and consumer-grade UTI diagnostics, offering competitive pricing and advanced testing methodologies.
| Attribute | Detail |
|---|---|
| Industry Size (2025E) | USD 5.47 billion |
| Industry Size (2035F) | USD 9.98 billion |
| CAGR (2025 to 2035) | 6.2% |
| Forecast Period | 2025 to 2035 |
| Historical Data | 2018 to 2024 |
| Base Year | 2024 |
| Quantitative Units | Value in USD billion, Volume in Number of UTI Test Kits, Urine Analyzers, and Consumables Sold |
| Segments Covered | Product, Test Type, Causative Organism, End User, Region |
| Regions Covered | North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, Middle East & Africa |
| Countries Covered | United States, Canada, Mexico, Brazil, Germany, UK, France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Australia, GCC Countries, South Africa |
| By Product | Urine Analyzers, Test Kits, Urine Collection Bags and Reagents, Consumables |
| By Test Type | Urinalysis, Urine Culture Analysis |
| By Causative Organism | Escherichia coli, Klebsiella pneumonia, Staphylococcus saprophyticus, Proteus mirabilis, Others |
| By End User | Hospital Laboratories, Reference Laboratories, Public Health Centres, Specialty Clinic, Ambulatory Surgical Centres, Academics and Research Institutes, Homecare Settings |
| Key Companies Profiled | Becton, Dickinson & Company, Cardinal Health, B. Braun SE, Coloplast, Medtronics, ConvaTec Group Plc, Teleflex Inc., Medline Industries, LP., Optimum Medical Limited, Polymedicure, AdvaCare Pharma, Well Lead Medical Co., Ltd., Advin Health Care |
| Additional Attributes | Market share by test type, unit sales of analyzers and kits, demand in hospital and homecare settings, causative organism detection trends, regional revenue, pricing dynamics, and top suppliers. |
Table 01: Global Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Test
Table 2A: Global Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Test Kits
Table 2B: Global Market Volume (Units) Analysis and Forecast 2017 to 2033, By Test Kits
Table 03: Global Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Indication
Table 04: Global Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User
Table 05: Global Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Region
Table 06: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 07: North America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Test
Table 08: North America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Test Kits
Table 09: North America Market Volume (Units) Analysis and Forecast 2017 to 2033, By Test Kits
Table 10: North America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Indication
Table 11: North America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User
Table 12: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 13: Latin America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Test
Table 14: Latin America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Test Kits
Table 15: Latin America Market Volume (Units) Analysis and Forecast 2017 to 2033, By Test Kits
Table 16: Latin America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Indication
Table 17: Latin America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User
Table 18: Europe Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 19: Europe Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Test
Table 20: Europe Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Test Kits
Table 21: Europe Market Volume (Units) Analysis and Forecast 2017 to 2033, By Test Kits
Table 22: Europe Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Indication
Table 23: Europe Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User
Table 24: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 25: South Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Test
Table 26: South Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Test Kits
Table 27: South Asia Market Volume (Units) Analysis and Forecast 2017 to 2033, By Test Kits
Table 28: South Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Indication
Table 29: South Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User
Table 30: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 31: East Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Test
Table 32: East Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Test Kits
Table 33: East Asia Market Volume (Units) Analysis and Forecast 2017 to 2033, By Test Kits
Table 34: East Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Indication
Table 35: East Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User
Table 36: Oceania Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 37: Oceania Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Test
Table 38: Oceania Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Test Kits
Table 39: Oceania Market Volume (Units) Analysis and Forecast 2017 to 2033, By Test Kits
Table 40: Oceania Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Indication
Table 41: Oceania Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User
Table 42: Middle East and Africa Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 43: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Test
Table 44: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Test Kits
Table 45: Middle East and Africa Market Volume (Units) Analysis and Forecast 2017 to 2033, By Test Kits
Table 46: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Indication
Table 47: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User
Figure 01: Global Market Volume (Units), 2017 to 2022
Figure 02: Global Market Volume (Units) & Y-o-Y Growth (%) Analysis,
Figure 03: Urinary Tract Infection Testing, Pricing Analysis per unit (US$), in 2022
Figure 04: Urinary Tract Infection Testing, Pricing Forecast per unit (US$), in 2033
Figure 05: Global Market Value (US$ Million) Analysis, 2017 to 2022
Figure 06: Global Market Forecast & Y-o-Y Growth, 2023 to 2033
Figure 07: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2022 to 2033
Figure 08: Global Market Value Share (%) Analysis 2023 and 2033, by Test
Figure 09: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Test
Figure 10: Global Market Attractiveness Analysis 2023 to 2033, by Test
Figure 11: Global Market Value Share (%) Analysis 2023 and 2033, By Test Kits
Figure 12: Global Market Y-o-Y Growth (%) Analysis 2022-2033, By Test Kits
Figure 13: Global Market Attractiveness Analysis 2023 to 2033, By Test Kits
Figure 14: Global Market Value Share (%) Analysis 2023 and 2033, by Indication
Figure 15: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Indication
Figure 16: Global Market Attractiveness Analysis 2023 to 2033, by Indication
Figure 17: Global Market Value Share (%) Analysis 2023 and 2033, by End User
Figure 18: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by End User
Figure 19: Global Market Attractiveness Analysis 2023 to 2033, by End User
Figure 20: Global Market Value Share (%) Analysis 2023 and 2033, by Region
Figure 21: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Region
Figure 22: Global Market Attractiveness Analysis 2023 to 2033, by Region
Figure 23: North America Market Value (US$ Million) Analysis, 2017 to 2022
Figure 24: North America Market Value (US$ Million) Forecast, 2023 to 2033
Figure 25: North America Market Value Share, by Test (2023 E)
Figure 26: North America Market Value Share, By Test Kits (2023 E)
Figure 27: North America Market Value Share, by Indication (2023 E)
Figure 28: North America Market Value Share, by End User (2023 E)
Figure 29: North America Market Value Share, by Country (2023 E)
Figure 30: North America Market Attractiveness Analysis by Test, 2023 to 2033
Figure 31: North America Market Attractiveness Analysis By Test Kits, 2023 to 2033
Figure 32: North America Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 33: North America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 34: North America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 35: USA Market Value Proportion Analysis, 2022
Figure 36: Global Vs. USA Growth Comparison
Figure 37: USA Market Share Analysis (%) by Test, 2022 & 2033
Figure 38: USA Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 39: USA Market Share Analysis (%) by Indication, 2022 & 2033
Figure 40: USA Market Share Analysis (%) by End User, 2022 & 2033
Figure 41: Canada Market Value Proportion Analysis, 2022
Figure 42: Global Vs. Canada. Growth Comparison
Figure 43: Canada Market Share Analysis (%) by Test, 2022 & 2033
Figure 44: Canada Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 45: Canada Market Share Analysis (%) by Indication, 2022 & 2033
Figure 46: Canada Market Share Analysis (%) by End User, 2022 & 2033
Figure 47: Latin America Market Value (US$ Million) Analysis, 2017 to 2022
Figure 48: Latin America Market Value (US$ Million) Forecast, 2023 to 2033
Figure 49: Latin America Market Value Share, by Test (2023 E)
Figure 50: Latin America Market Value Share, By Test Kits (2023 E)
Figure 51: Latin America Market Value Share, by Indication (2023 E)
Figure 52: Latin America Market Value Share, by End User (2023 E)
Figure 53: Latin America Market Value Share, by Country (2023 E)
Figure 54: Latin America Market Attractiveness Analysis by Test, 2023 to 2033
Figure 55: Latin America Market Attractiveness Analysis By Test Kits, 2023 to 2033
Figure 56: Latin America Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 57: Latin America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 58: Latin America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 59: Mexico Market Value Proportion Analysis, 2022
Figure 60: Global Vs Mexico Growth Comparison
Figure 61: Mexico Market Share Analysis (%) by Test, 2022 & 2033
Figure 62: Mexico Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 63: Mexico Market Share Analysis (%) by Indication, 2022 & 2033
Figure 64: Mexico Market Share Analysis (%) by End User, 2022 & 2033
Figure 65: Brazil Market Value Proportion Analysis, 2022
Figure 66: Global Vs. Brazil. Growth Comparison
Figure 67: Brazil Market Share Analysis (%) by Test, 2022 & 2033
Figure 68: Brazil Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 69: Brazil Market Share Analysis (%) by Indication, 2022 & 2033
Figure 70: Brazil Market Share Analysis (%) by End User, 2022 & 2033
Figure 71: Argentina Market Value Proportion Analysis, 2022
Figure 72: Global Vs Argentina Growth Comparison
Figure 73: Argentina Market Share Analysis (%) by Test, 2022 & 2033
Figure 74: Argentina Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 75: Argentina Market Share Analysis (%) by Indication, 2022 & 2033
Figure 76: Argentina Market Share Analysis (%) by End User, 2022 & 2033
Figure 77: Europe Market Value (US$ Million) Analysis, 2017 to 2022
Figure 78: Europe Market Value (US$ Million) Forecast, 2023 to 2033
Figure 79: Europe Market Value Share, by Test (2023 E)
Figure 80: Europe Market Value Share, By Test Kits (2023 E)
Figure 81: Europe Market Value Share, by Indication (2023 E)
Figure 82: Europe Market Value Share, by End User (2023 E)
Figure 83: Europe Market Value Share, by Country (2023 E)
Figure 84: Europe Market Attractiveness Analysis by Test, 2023 to 2033
Figure 85: Europe Market Attractiveness Analysis By Test Kits, 2023 to 2033
Figure 86: Europe Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 87: Europe Market Attractiveness Analysis by End User, 2023 to 2033
Figure 88: Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 89: UK Market Value Proportion Analysis, 2022
Figure 90: Global Vs. UK Growth Comparison
Figure 91: UK Market Share Analysis (%) by Test, 2022 & 2033
Figure 92: UK Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 93: UK Market Share Analysis (%) by Indication, 2022 & 2033
Figure 94: UK Market Share Analysis (%) by End User, 2022 & 2033
Figure 95: Germany Market Value Proportion Analysis, 2022
Figure 96: Global Vs. Germany Growth Comparison
Figure 97: Germany Market Share Analysis (%) by Test, 2022 & 2033
Figure 98: Germany Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 99: Germany Market Share Analysis (%) by Indication, 2022 & 2033
Figure 100: Germany Market Share Analysis (%) by End User, 2022 & 2033
Figure 101: Italy Market Value Proportion Analysis, 2022
Figure 102: Global Vs. Italy Growth Comparison
Figure 103: Italy Market Share Analysis (%) by Test, 2022 & 2033
Figure 104: Italy Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 105: Italy Market Share Analysis (%) by Indication, 2022 & 2033
Figure 106: Italy Market Share Analysis (%) by End User, 2022 & 2033
Figure 107: France Market Value Proportion Analysis, 2022
Figure 108: Global Vs France Growth Comparison
Figure 109: France Market Share Analysis (%) by Test, 2022 & 2033
Figure 110: France Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 111: France Market Share Analysis (%) by Indication, 2022 & 2033
Figure 112: France Market Share Analysis (%) by End User, 2022 & 2033
Figure 113: Spain Market Value Proportion Analysis, 2022
Figure 114: Global Vs Spain Growth Comparison
Figure 115: Spain Market Share Analysis (%) by Test, 2022 & 2033
Figure 116: Spain Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 117: Spain Market Share Analysis (%) by Indication, 2022 & 2033
Figure 118: Spain Market Share Analysis (%) by End User, 2022 & 2033
Figure 119: Russia Market Value Proportion Analysis, 2022
Figure 120: Global Vs Russia Growth Comparison
Figure 121: Russia Market Share Analysis (%) by Test, 2022 & 2033
Figure 122: Russia Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 123: Russia Market Share Analysis (%) by Indication, 2022 & 2033
Figure 124: Russia Market Share Analysis (%) by End User, 2022 & 2033
Figure 125: BENELUX Market Value Proportion Analysis, 2022
Figure 126: Global Vs BENELUX Growth Comparison
Figure 127: BENELUX Market Share Analysis (%) by Test, 2022 & 2033
Figure 128: BENELUX Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 129: BENELUX Market Share Analysis (%) by Indication, 2022 & 2033
Figure 130: BENELUX Market Share Analysis (%) by End User, 2022 & 2033
Figure 131: East Asia Market Value (US$ Million) Analysis, 2017 to 2022
Figure 132: East Asia Market Value (US$ Million) Forecast, 2023 to 2033
Figure 133: East Asia Market Value Share, by Test (2023 E)
Figure 134: East Asia Market Value Share, By Test Kits (2023 E)
Figure 135: East Asia Market Value Share, by Indication (2023 E)
Figure 136: East Asia Market Value Share, by End User (2023 E)
Figure 137: East Asia Market Value Share, by Country (2023 E)
Figure 138: East Asia Market Attractiveness Analysis by Test, 2023 to 2033
Figure 139: East Asia Market Attractiveness Analysis By Test Kits, 2023 to 2033
Figure 140: East Asia Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 141: East Asia Market Attractiveness Analysis by End User, 2023 to 2033
Figure 142: East Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 143: China Market Value Proportion Analysis, 2022
Figure 144: Global Vs. China Growth Comparison
Figure 145: China Market Share Analysis (%) by Test, 2022 & 2033
Figure 146: China Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 147: China Market Share Analysis (%) by Indication, 2022 & 2033
Figure 148: China Market Share Analysis (%) by End User, 2022 & 2033
Figure 149: Japan Market Value Proportion Analysis, 2022
Figure 150: Global Vs. Japan Growth Comparison
Figure 151: Japan Market Share Analysis (%) by Test, 2022 & 2033
Figure 152: Japan Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 153: Japan Market Share Analysis (%) by Indication, 2022 & 2033
Figure 154: Japan Market Share Analysis (%) by End User, 2022 & 2033
Figure 155: South Korea Market Value Proportion Analysis, 2022
Figure 156: Global Vs South Korea Growth Comparison
Figure 157: South Korea Market Share Analysis (%) by Test, 2022 & 2033
Figure 158: South Korea Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 159: South Korea Market Share Analysis (%) by Indication, 2022 & 2033
Figure 160: South Korea Market Share Analysis (%) by End User, 2022 & 2033
Figure 161: South Asia Market Value (US$ Million) Analysis, 2017 to 2022
Figure 162: South Asia Market Value (US$ Million) Forecast, 2023 to 2033
Figure 163: South Asia Market Value Share, by Test (2023 E)
Figure 164: South Asia Market Value Share, By Test Kits (2023 E)
Figure 165: South Asia Market Value Share, by Indication (2023 E)
Figure 166: South Asia Market Value Share, by End User (2023 E)
Figure 167: South Asia Market Value Share, by Country (2023 E)
Figure 168: South Asia Market Attractiveness Analysis by Test, 2023 to 2033
Figure 169: South Asia Market Attractiveness Analysis By Test Kits, 2023 to 2033
Figure 170: South Asia Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 171: South Asia Market Attractiveness Analysis by End User, 2023 to 2033
Figure 172: South Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 173: India Market Value Proportion Analysis, 2022
Figure 174: Global Vs. India Growth Comparison
Figure 175: India Market Share Analysis (%) by Test, 2022 & 2033
Figure 176: India Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 177: India Market Share Analysis (%) by Indication, 2022 & 2033
Figure 178: India Market Share Analysis (%) by End User, 2022 & 2033
Figure 179: Indonesia Market Value Proportion Analysis, 2022
Figure 180: Global Vs. Indonesia Growth Comparison
Figure 181: Indonesia Market Share Analysis (%) by Test, 2022 & 2033
Figure 182: Indonesia Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 183: Indonesia Market Share Analysis (%) by Indication, 2022 & 2033
Figure 184: Indonesia Market Share Analysis (%) by End User, 2022 & 2033
Figure 185: Malaysia Market Value Proportion Analysis, 2022
Figure 186: Global Vs. Malaysia Growth Comparison
Figure 187: Malaysia Market Share Analysis (%) by Test, 2022 & 2033
Figure 188: Malaysia Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 189: Malaysia Market Share Analysis (%) by Indication, 2022 & 2033
Figure 190: Malaysia Market Share Analysis (%) by End User, 2022 & 2033
Figure 191: Thailand Market Value Proportion Analysis, 2022
Figure 192: Global Vs. Thailand Growth Comparison
Figure 193: Thailand Market Share Analysis (%) by Test, 2022 & 2033
Figure 194: Thailand Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 195: Thailand Market Share Analysis (%) by Indication, 2022 & 2033
Figure 196: Thailand Market Share Analysis (%) by End User, 2022 & 2033
Figure 197: Oceania Market Value (US$ Million) Analysis, 2017 to 2022
Figure 198: Oceania Market Value (US$ Million) Forecast, 2023 to 2033
Figure 199: Oceania Market Value Share, by Test (2023 E)
Figure 200: Oceania Market Value Share, By Test Kits (2023 E)
Figure 201: Oceania Market Value Share, by Indication (2023 E)
Figure 202: Oceania Market Value Share, by End User (2023 E)
Figure 203: Oceania Market Value Share, by Country (2023 E)
Figure 204: Oceania Market Attractiveness Analysis by Test, 2023 to 2033
Figure 205: Oceania Market Attractiveness Analysis By Test Kits, 2023 to 2033
Figure 206: Oceania Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 207: Oceania Market Attractiveness Analysis by End User, 2023 to 2033
Figure 208: Oceania Market Attractiveness Analysis by Country, 2023 to 2033
Figure 209: Australia Market Value Proportion Analysis, 2022
Figure 210: Global Vs. Australia Growth Comparison
Figure 211: Australia Market Share Analysis (%) by Test, 2022 & 2033
Figure 212: Australia Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 213: Australia Market Share Analysis (%) by Indication, 2022 & 2033
Figure 214: Australia Market Share Analysis (%) by End User, 2022 & 2033
Figure 215: New Zealand Market Value Proportion Analysis, 2022
Figure 216: Global Vs New Zealand Growth Comparison
Figure 217: New Zealand Market Share Analysis (%) by Test, 2022 & 2033
Figure 218: New Zealand Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 219: New Zealand Market Share Analysis (%) by Indication, 2022 & 2033
Figure 220: New Zealand Market Share Analysis (%) by End User, 2022 & 2033
Figure 221: Middle East & Africa Market Value (US$ Million) Analysis, 2017 to 2022
Figure 222: Middle East & Africa Market Value (US$ Million) Forecast, 2023 to 2033
Figure 223: Middle East & Africa Market Value Share, by Test (2023 E)
Figure 224: Middle East & Africa Market Value Share, By Test Kits (2023 E)
Figure 225: Middle East & Africa Market Value Share, by Indication (2023 E)
Figure 226: Middle East & Africa Market Value Share, by End User (2023 E)
Figure 227: Middle East & Africa Market Value Share, by Country (2023 E)
Figure 228: Middle East & Africa Market Attractiveness Analysis by Test, 2023 to 2033
Figure 229: Middle East & Africa Market Attractiveness Analysis By Test Kits, 2023 to 2033
Figure 230: Middle East & Africa Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 231: Middle East & Africa Market Attractiveness Analysis by End User, 2023 to 2033
Figure 232: Middle East & Africa Market Attractiveness Analysis by Country, 2023 to 2033
Figure 233: GCC Countries Market Value Proportion Analysis, 2022
Figure 234: Global Vs GCC Countries Growth Comparison
Figure 235: GCC Countries Market Share Analysis (%) by Test, 2022 & 2033
Figure 236: GCC Countries Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 237: GCC Countries Market Share Analysis (%) by Indication, 2022 & 2033
Figure 238: GCC Countries Market Share Analysis (%) by End User, 2022 & 2033
Figure 239: Türkiye Market Value Proportion Analysis, 2022
Figure 240: Global Vs. Türkiye Growth Comparison
Figure 241: Türkiye Market Share Analysis (%) by Test, 2022 & 2033
Figure 242: Türkiye Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 243: Türkiye Market Share Analysis (%) by Indication, 2022 & 2033
Figure 244: Türkiye Market Share Analysis (%) by End User, 2022 & 2033
Figure 245: South Africa Market Value Proportion Analysis, 2022
Figure 246: Global Vs. South Africa Growth Comparison
Figure 247: South Africa Market Share Analysis (%) by Test, 2022 & 2033
Figure 248: South Africa Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 249: South Africa Market Share Analysis (%) by Indication, 2022 & 2033
Figure 250: South Africa Market Share Analysis (%) by End User, 2022 & 2033
Figure 251: Northern Africa Market Value Proportion Analysis, 2022
Figure 252: Global Vs Northern Africa Growth Comparison
Figure 253: Northern Africa Market Share Analysis (%) by Test, 2022 & 2033
Figure 254: Northern Africa Market Share Analysis (%) By Test Kits, 2022 & 2033
Figure 255: Northern Africa Market Share Analysis (%) by Indication, 2022 & 2033
Figure 256: Northern Africa Market Share Analysis (%) by End User, 2022 & 2033
The global Urinary Tract Infection Testing industry is projected to witness CAGR of 6.2% between 2025 and 2035.
The global Urinary Tract Infection Testing industry stood at USD 5.12 billion in 2024.
The global Urinary Tract Infection Testing industry is anticipated to reach USD 9.98 billion by 2035 end.
ASEAN Countries is expected to show a CAGR of 7.5% in the assessment period.
The key players operating in the global Urinary Tract Infection Testing industry are F. Hoffmann-La Roche AG, Siemens Healthineers AG, Danaher, Thermo fisher Scientific, Abbott, QIAGEN N.V., Bio-Rad Laboratories, Inc., Randox Laboratories Ltd., T2 Biosystems, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd, ARKRAY, Inc.AGAPPE DIAGNOSTICS SWITZERLAND GmbH The Menarini Group and others
Explore Similar Insights
Urinary Tract Infection Testing Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
